Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2)
about
LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidenceCrystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.Identification of the linear epitope for Fc-binding on the bovine IgG2 Fc receptor (boFcgamma2R) using synthetic peptidesIg-like transcript 4 inhibits lipid antigen presentation through direct CD1d interactionHigh affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activationHuman inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-GInsights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-FcCrystal structure of the ectodomain of human FcalphaRICrystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptorCrystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptorsStructure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptorKIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A * 11 while diminishing avidity for HLA-CCrystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k): A MYELOID INHIBITORY RECEPTOR INVOLVED IN IMMUNE TOLERANCECrystal structures of the two membrane-proximal Ig-like domains (D3D4) of LILRB1/B2: alternative models for their involvement in peptide-HLA bindingCD8 alpha is expressed by human monocytes and enhances Fc gamma R-dependent responses.A potential role for shed soluble major histocompatibility class I molecules as modulators of neurite outgrowth.Origin and evolution of the chicken leukocyte receptor complex.Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state.The LILR family: modulators of innate and adaptive immune pathways in health and disease.Survey of the year 2000 commercial optical biosensor literature.Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family.Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.The influence of N-linked glycosylation on the function of platelet glycoprotein VINK cells and trophoblasts: partners in pregnancy.Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection.Structural insights into activation of antiviral NK cell responsesStructural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.Structural basis of collagen recognition by human osteoclast-associated receptor and design of osteoclastogenesis inhibitorsNatural killer cells and their receptors in multiple sclerosis.Glycosylation in a mammalian expression system is critical for the production of functionally active leukocyte immunoglobulin-like receptor A3 protein.Structural basis for recognition of cellular and viral ligands by NK cell receptors.Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions.Human natural killer cell receptor functions and their implication in diseases.The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection.How do pathogens drive the evolution of paired receptors?Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.The Expanding Spectrum of Ligands for Leukocyte Ig-like Receptors.Interaction of the LILRB1 inhibitory receptor with HLA class Ia dimers.Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against multiple myeloma.
P2860
Q21091044-6025F905-929E-46C1-A8AC-ABE712E062BDQ21256433-A8DC2739-F0C6-46B8-80AA-3C1FAF3092B4Q24303610-5CE59CD1-DDCC-4B7F-9C3D-6D2F6BA0E0E4Q24313634-BD6B9135-A047-471D-8814-ABDE8B0D62BAQ24324563-8ABBEBBF-7642-4CD8-8E1D-03CF11F3C460Q24678795-2CA17194-7EDE-4F6F-9423-49F736A45BF6Q27641329-C365DCAF-84C8-4AA0-99B7-8D95517A338EQ27641379-708EB934-B091-4EBC-B0B6-DC864DCC7DE7Q27641776-0BCFED9A-1543-403E-807A-A772FDD9C9CDQ27641970-DE35BAB3-5B5E-4C2E-822A-23ECD3532B13Q27651216-CB139CF7-ACC8-419E-96F4-87ADA704EC3AQ27657994-0FC65777-FF6A-4381-A4B0-E185BE2C61ACQ27667381-4E91CA43-77FA-4DF5-852A-CFEC0616ADB8Q27679716-FAF33234-898A-4269-86A0-3F1F61B5B06DQ33293227-88422F2C-D04E-49B1-AB0C-8C9C15702499Q33869614-8B04F093-A689-4366-843B-36EAF234CD23Q33932720-A4128355-5948-45B6-B302-DC1078BFC293Q34245022-ED96B92B-0643-4524-B9F2-0CC2DCB699BFQ34340048-5F7C86D2-E71C-48DB-B218-0B692CAC12BAQ34464911-FDBEB83C-1158-4B90-B299-EA349E489153Q35030968-10DFF1BF-37D7-4F1E-9725-4B69F8536628Q35133849-932C4F46-5EC5-41C8-A03B-99558AA22A91Q35678024-020587F0-F779-4299-A686-E146B0F458A7Q35848393-7986E8EB-4ED3-445D-A1E8-D833094FA927Q35921864-8472E1EE-4725-4B7B-A4FB-4BD063612CD2Q35964751-C5CBED7E-B4D2-4830-AA4D-EDC146E2F722Q36317668-6EC02B6D-117F-4C2F-A816-DD07F2485DE5Q36493811-F5915703-33D0-4299-8F7E-263065248598Q36551591-ECB4EEF4-A77F-4B74-BDA3-A08816D2B8C8Q37124504-2AD58C13-2044-49A7-8422-91E5E7C773DAQ37311324-83F05477-D791-4337-857B-546CBC33EEBBQ37678862-3A4F54CB-0E13-4FEA-AD7C-F7B3DD7B1009Q37685690-54A7C018-F15F-4BA2-8C64-E785D13E902AQ37754620-96F049B0-9209-4709-A3F0-DC327349DD72Q37949561-C2B5B893-F080-45E2-AFDD-84435EF09103Q38070978-4F68E788-0E57-4A9F-BC8B-5744ECFE335CQ38659065-A9FD5B5F-EEC8-4A32-AF72-0458DBB800E7Q38708560-9D9BBC00-56FB-459E-9A19-41ACF2545D58Q38775795-AF76CB19-E596-4FF2-9A3F-6C88E349AC14Q39306266-CBE03AF5-4591-4118-9C77-854928C9E63D
P2860
Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2)
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Crystal structure and ligand b ...... hibitory receptor LIR-1 (ILT2)
@ast
Crystal structure and ligand b ...... hibitory receptor LIR-1 (ILT2)
@en
Crystal structure and ligand b ...... hibitory receptor LIR-1 (ILT2)
@nl
type
label
Crystal structure and ligand b ...... hibitory receptor LIR-1 (ILT2)
@ast
Crystal structure and ligand b ...... hibitory receptor LIR-1 (ILT2)
@en
Crystal structure and ligand b ...... hibitory receptor LIR-1 (ILT2)
@nl
prefLabel
Crystal structure and ligand b ...... hibitory receptor LIR-1 (ILT2)
@ast
Crystal structure and ligand b ...... hibitory receptor LIR-1 (ILT2)
@en
Crystal structure and ligand b ...... hibitory receptor LIR-1 (ILT2)
@nl
P2093
P1433
P1476
Crystal structure and ligand b ...... hibitory receptor LIR-1 (ILT2)
@en
P2093
A P Heikema
P J Bjorkman
T L Chapman
P304
P356
10.1016/S1074-7613(00)00071-6
P407
P577
2000-11-01T00:00:00Z